| Chris S Chung, MD | |
|
8008 Westpark Dr, Mc Lean, VA 22102-3109 | |
| (703) 287-6400 | |
| Not Available |
| Full Name | Chris S Chung |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 22 Years |
| Location | 8008 Westpark Dr, Mc Lean, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134381791 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 0101256351 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
| Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Elsevier, the world's leading publisher of scientific, technical, and medical information products and services, today announced an exclusive partnership with The American Society of Radiologic Technologists (ASRT) to provide a complete series of computed tomography modules through Mosby's Imaging Suite for technologists' continuing education. This partnership will provide technologists access to the highest quality continuing education, and will give hospital management the best tools to ensure patient safety.
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals today announced that its aseptic filling facility is again fully operational and SynCo has produced and released the first drug product batches for its clients after the expansion of its Class A zone.
New two-year data from the Phase 3 ADVANCE clinical trial for peginterferon beta-1a in adults with relapsing forms of multiple sclerosis (RMS) has been presented at the 66th American Academy of Neurology (AAN) annual meeting.
› Verified 7 days ago
| Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Elsevier, the world's leading publisher of scientific, technical, and medical information products and services, today announced an exclusive partnership with The American Society of Radiologic Technologists (ASRT) to provide a complete series of computed tomography modules through Mosby's Imaging Suite for technologists' continuing education. This partnership will provide technologists access to the highest quality continuing education, and will give hospital management the best tools to ensure patient safety.
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals today announced that its aseptic filling facility is again fully operational and SynCo has produced and released the first drug product batches for its clients after the expansion of its Class A zone.
New two-year data from the Phase 3 ADVANCE clinical trial for peginterferon beta-1a in adults with relapsing forms of multiple sclerosis (RMS) has been presented at the 66th American Academy of Neurology (AAN) annual meeting.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chris S Chung, MD 8008 Westpark Dr, Mc Lean, VA 22102-3109 Ph: () - | Chris S Chung, MD 8008 Westpark Dr, Mc Lean, VA 22102-3109 Ph: (703) 287-6400 |
News Archive
Elsevier, the world's leading publisher of scientific, technical, and medical information products and services, today announced an exclusive partnership with The American Society of Radiologic Technologists (ASRT) to provide a complete series of computed tomography modules through Mosby's Imaging Suite for technologists' continuing education. This partnership will provide technologists access to the highest quality continuing education, and will give hospital management the best tools to ensure patient safety.
MorphoSys AG and Boehringer Ingelheim announced today the signing of a biopharmaceutical manufacturing agreement for therapeutic antibodies. The agreement covers the process development and manufacturing of additional clinical material for MorphoSys's proprietary MOR208 program and other drug candidates. MOR208, a potent monoclonal anti-CD19 antibody, is in development for the treatment of chronic lymphocytic leukemia and potentially other B-cell malignancies. The program is currently being evaluated in a phase 1 clinical trial in the USA by MorphoSys's partner Xencor Inc.
SynCo Bio Partners B.V., one of the leading GMP contract manufacturers of biopharmaceuticals today announced that its aseptic filling facility is again fully operational and SynCo has produced and released the first drug product batches for its clients after the expansion of its Class A zone.
New two-year data from the Phase 3 ADVANCE clinical trial for peginterferon beta-1a in adults with relapsing forms of multiple sclerosis (RMS) has been presented at the 66th American Academy of Neurology (AAN) annual meeting.
› Verified 7 days ago
Alexis Leigh Crawley, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8008 Westpark Dr, Mc Lean, VA 22102 Phone: 703-287-6400 | |
Dr. Nordine Gaugau, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 6723 Whittier Ave, Ste 306, Mc Lean, VA 22101 Phone: 703-891-3147 | |
Dr. Margaret Kang, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1021 Broad Branch Ct, Mc Lean, VA 22101 Phone: 952-595-1100 Fax: 612-294-4903 | |
Matthew Joseph Webber, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8008 Westpark Dr, Mc Lean, VA 22102 Phone: 703-287-6400 | |
Dr. Omar Javery, Radiology Medicare: Accepting Medicare Assignments Practice Location: 8008 Westpark Dr, Mc Lean, VA 22102 Phone: 703-287-6400 | |
Dr. Anjum Bandarkar, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8008 Westpark Dr, Mc Lean, VA 22102 Phone: 703-287-1910 |